Gynecology

Cabrostinex 0.5mg Tablet

Indication:

Inhibition of physiological lactation. Suppression of already established lactation, treatment of disorders associated with hyperprolactinemia, including amenorrhoea, oligomenorrhea, anovulation and galactorrhoea, also indicated in patients with prolactin-secreting pituitary adenomas (micro- and macroprolactinomas), idiopathic hyperprolactinemia.

How it works:

Dopamine D2 Receptor Agonist which results in the Normalization of Serum Prolactin Hormone.

How to use:

For inhibition of lactation should be administered during the first day post-partum. The recommended therapeutic dose is 1 mg (two 0.5 mg tablets) given as a single dose.
For suppression of established lactation the recommended therapeutic dosage regimen is 0.25 mg (one-half 0.5 mg tablet) every 12 hours for two days (1 mg total dose).
For Treatment of hyperprolactinaemic disorders 0.5 mg per week given in one or two (one-half of one 0.5 mg tablet) doses (e.g. on Monday and Thursday) per week till symptoms resolution.

 

Active Ingredient Function Concentration
Cabergoline Serum Prolactin Hormone Normalization 0.5 mg tablet